IL114118A0 - Novel cell systems having specific interaction of peptide binding pairs - Google Patents

Novel cell systems having specific interaction of peptide binding pairs

Info

Publication number
IL114118A0
IL114118A0 IL11411895A IL11411895A IL114118A0 IL 114118 A0 IL114118 A0 IL 114118A0 IL 11411895 A IL11411895 A IL 11411895A IL 11411895 A IL11411895 A IL 11411895A IL 114118 A0 IL114118 A0 IL 114118A0
Authority
IL
Israel
Prior art keywords
peptide
transcriptional activation
fusion protein
protein
host cell
Prior art date
Application number
IL11411895A
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL114118A0 publication Critical patent/IL114118A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to novel modified host cells which express heterologous fused proteins and methods of screening for test samples having peptide-binding activity; wherein the modified host cell comprises: (a) a gene sequence encoding a heterologous fusion protein; said fusion protein comprising a first peptide of a peptide binding pair, or segment of said first peptide, which is joined to either a DNA binding domain or its corresponding transcriptional activation domain of a transcriptional activation protein; (b) a gene sequence encoding a heterologous fusion protein, said fusion protein comprising a second peptide of the peptide binding pair in (a), or a segment thereof, fused to either a DNA binding domain or its corresponding transcriptional activation domain, whichever one is not employed in (a); (c) a reporter gene operatively associated with the transcriptional activation protein, or a portion thereof; (d) optionally, a deletion or mutation in the chromosomal DNA of the host cell for the transcriptional activation protein if present in the selected host cell.
IL11411895A 1994-06-14 1995-06-12 Novel cell systems having specific interaction of peptide binding pairs IL114118A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/259,609 US5989808A (en) 1994-06-14 1994-06-14 Identification of compounds affecting specific interaction of peptide binding pairs

Publications (1)

Publication Number Publication Date
IL114118A0 true IL114118A0 (en) 1995-10-31

Family

ID=22985626

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11411895A IL114118A0 (en) 1994-06-14 1995-06-12 Novel cell systems having specific interaction of peptide binding pairs

Country Status (18)

Country Link
US (3) US5989808A (en)
EP (1) EP0765389B1 (en)
AT (1) ATE245189T1 (en)
AU (1) AU706173B2 (en)
CA (1) CA2195083A1 (en)
DE (1) DE69531302T2 (en)
DK (1) DK0765389T3 (en)
ES (1) ES2202366T3 (en)
GE (1) GEP20022619B (en)
IL (1) IL114118A0 (en)
LT (1) LT4230B (en)
LV (1) LV11906B (en)
NZ (1) NZ287372A (en)
PT (1) PT765389E (en)
RU (1) RU2208646C2 (en)
SI (1) SI9520073B (en)
WO (1) WO1995034646A1 (en)
ZA (1) ZA954892B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226761B2 (en) * 1992-11-05 2007-06-05 Danisco Sweeteners Oy Manufacture of five-carbon sugars and sugar alcohols
US6891021B2 (en) 1993-02-12 2005-05-10 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
US6972193B1 (en) * 1993-02-12 2005-12-06 Board Of Trustees Of Leland Stanford Junior University Regulated transcription of targeted genes and other biological events
US6770446B1 (en) * 1994-06-14 2004-08-03 Wyeth Cell systems having specific interaction of peptide binding pairs
US5610015A (en) * 1995-03-23 1997-03-11 Wisconsin Alumni Research Foundation System to detect protein-RNA interactions
AU716893B2 (en) * 1995-04-11 2000-03-09 General Hospital Corporation, The Reverse two-hybrid systems
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
DE29724617U1 (en) * 1996-04-26 2002-06-13 Massachusetts Institute Of Technology, Cambridge, Mass. Three hybrid kit for molecular selection
JP2000508923A (en) * 1996-04-26 2000-07-18 マサチューセッツ・インスティテュート・オブ・テクノロジー 3-Hybrid screening assay
US6696251B1 (en) 1996-05-31 2004-02-24 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
WO1997049808A1 (en) * 1996-06-27 1997-12-31 Biogen, Inc. The caip-like gene family
FR2761697B1 (en) * 1997-04-03 1999-05-28 Inst Nat Sante Rech Med METHODS OF DETECTING INTERACTIONS BETWEEN MULTIPLE PROTEINS
DE19715683C2 (en) * 1997-04-15 1999-11-11 Max Planck Gesellschaft New reporter vectors for one-hybrid and two-hybrid systems
US7005295B1 (en) 1997-04-16 2006-02-28 Wyeth β-amyloid peptide-binding proteins and polynucleotides encoding the same
US6787319B2 (en) 1997-04-16 2004-09-07 American Home Products Corp. β-amyloid peptide-binding proteins and polynucleotides encoding the same
PT977846E (en) 1997-04-25 2002-11-29 Wyeth Corp NEURONAL MORTIE ISOFORMS
US6479653B1 (en) 1997-08-26 2002-11-12 Ariad Gene Therapeutics, Inc. Compositions and method for regulation of transcription
JP4296608B2 (en) * 1997-08-27 2009-07-15 田辺三菱製薬株式会社 PPAR agonist and antagonist screening method
WO1999019518A1 (en) 1997-10-15 1999-04-22 Diversa, Inc. Screening for novel compounds which regulate biological interactions
EP1149920A1 (en) * 1997-10-15 2001-10-31 Diversa, Inc. Screening for novel compounds which regulate biological interactions
US6261842B1 (en) 1997-10-23 2001-07-17 Wisconsin Alumni Research Foundation Microorganism genomics, compositions and methods related thereto
CA2309763A1 (en) * 1997-11-14 1999-05-27 Roche Diagnostics Corporation Variable region fusion peptides that form effector complexes in the presence of antigen
CA2317816C (en) 1998-01-09 2009-02-17 Tvw Telethon Institute For Child Health Research Peptide detection method
EP0974649A1 (en) * 1998-06-22 2000-01-26 Universität Zürich Screening system
US7166475B2 (en) 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
GB9907687D0 (en) * 1999-04-01 1999-05-26 Kudos Pharm Ltd Assays methods and means
WO2000063667A2 (en) 1999-04-21 2000-10-26 American Home Products Corporation Methods for identifying modulators of n-type ion channel inactivation
AU2001257157A1 (en) * 2000-04-24 2001-11-07 Wyeth Novel cell systems having specific interaction of peptide binding pairs
ZA200301579B (en) 2000-08-25 2004-06-21 Basf Plant Science Gmbh Plant polynucleotides encoding prenyl proteases.
WO2002046400A2 (en) * 2000-12-08 2002-06-13 The Board Of Trustees Of The University Of Illinois Mutated class ii major histocompatibility proteins
NZ538464A (en) 2002-08-21 2008-01-31 Revivicor Inc Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
WO2005049804A2 (en) * 2003-11-17 2005-06-02 Georgia Tech Research Corporation Engineering enzymes through genetic selection
EP1544307A1 (en) * 2003-12-18 2005-06-22 AXXAM S.r.l. LAC9 chimeric receptor and uses thereof
EP1774017B1 (en) 2004-07-26 2013-05-15 Pfenex Inc. Process for improved protein expression by strain engineering
WO2007035213A2 (en) 2005-08-09 2007-03-29 Revivicor, Inc. Transgenic ungulates expressing ctla4-ig and uses thereof
US20070196872A1 (en) * 2006-02-07 2007-08-23 Wyeth Materials and methods for identifying agents that modulate Norrin, Norrin mimetics, and agents identified thereby
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CA2685326A1 (en) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CN101131363B (en) * 2007-09-30 2010-12-01 南京大学 Yeast triple-hybridization based small molecule compound detecting method
WO2016154452A2 (en) 2015-03-24 2016-09-29 Osiris Therapeutics, Inc. Compositions comprising meniscal tissues and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5322801A (en) * 1990-04-19 1994-06-21 The General Hospital Corporation Protein partner screening assays and uses thereof
JP3537141B2 (en) * 1992-10-30 2004-06-14 ザ ゼネラル ホスピタル コーポレーション Interaction-based capture system for separation of new proteins
US5512473A (en) * 1993-01-29 1996-04-30 Brent; Roger Max-interacting proteins and related molecules and methods
US5582995A (en) * 1993-06-11 1996-12-10 The General Hospital Corporation Methods of screening for compounds which inhibit the direct binding of Ras to Raf
WO1995018380A1 (en) * 1993-12-30 1995-07-06 The Salk Institute For Biological Studies Novel uses for gal4-receptor constructs
ATE190984T1 (en) * 1994-01-21 2000-04-15 Icos Corp MATERIALS AND METHODS RELATING TO CASEIN KINASE I INTERACTING PROTEINS
US5525490A (en) * 1994-03-29 1996-06-11 Onyx Pharmaceuticals, Inc. Reverse two-hybrid method
US5691147A (en) * 1994-06-02 1997-11-25 Mitotix, Inc. CDK4 binding assay

Also Published As

Publication number Publication date
US6251602B1 (en) 2001-06-26
LV11906B (en) 1998-06-20
GEP20022619B (en) 2002-01-25
NZ287372A (en) 1997-11-24
ES2202366T3 (en) 2004-04-01
PT765389E (en) 2003-11-28
US5989808A (en) 1999-11-23
CA2195083A1 (en) 1995-12-21
DE69531302T2 (en) 2004-04-22
ATE245189T1 (en) 2003-08-15
LT4230B (en) 1997-10-27
AU706173B2 (en) 1999-06-10
AU2606695A (en) 1996-01-05
EP0765389A1 (en) 1997-04-02
DK0765389T3 (en) 2003-10-27
RU2208646C2 (en) 2003-07-20
EP0765389B1 (en) 2003-07-16
ZA954892B (en) 1996-01-30
LV11906A (en) 1997-12-20
LT97004A (en) 1997-07-25
WO1995034646A1 (en) 1995-12-21
SI9520073A (en) 1998-02-28
US6284519B1 (en) 2001-09-04
DE69531302D1 (en) 2003-08-21
SI9520073B (en) 2004-06-30

Similar Documents

Publication Publication Date Title
LT97004A (en) Novel cell systems having specific interaction of peptide binding pairs
ES8602119A1 (en) Recombinant immunoglobulin preparations, methods for their preparation, DNA sequences, expression vectors and recombinant host cells therefor.
EP1559776A3 (en) Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system and promoters and terminators for use therein
DK600486D0 (en) IgG binding PROTEIN
ATE238550T1 (en) MARKING AND SELECTION OF MOLECULES
DE69535147D1 (en) OVEREXPRESSION OF MAMMAL AND VIRUS PROTEINS
DK61595A (en) Recombinant DNA molecules, host cell transformation thereof, host cells containing them, and method for producing an IFN alpha type polypeptide
HK1013847A1 (en) Gdf-1 and uog-1 proteins
WO1999043808A8 (en) Human c-maf compositions and methods of use thereof
ATE311443T1 (en) METHODS FOR SCREENING PROTEINS
WO2000009730A3 (en) Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO1995014778A3 (en) Dna sequence coding for a bmp receptor
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
Board Genetic heterogeneity of the B subunit of coagulation factor XIII: resolution of type 2
WO2001094383A3 (en) Mutated furin polypeptides having improved characteristics
WO2000012544A3 (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
DK0750637T3 (en) CAI resistance encoding a protein and its use
ATE346919T1 (en) Epididymis-SPECIFIC RECEPTOR PROTEIN AND USE THEREOF
WO2002050104A3 (en) Methods and cells for detecting modulators of rgs proteins
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
NO20012471L (en) Potassium channel interactors and uses thereof
WO2000027874A3 (en) Nucleic acids encoding transferrin receptor-like proteins and products related thereto
EA200300420A1 (en) Isolated nucleic acid molecules, isolated polypeptides AND METHOD FOR PRODUCTION THEREOF, METHOD FOR DETECTING THEM present in the sample (VARIANTS) host cell (VARIANTS) antibody kit (OPTIONS), a method of modulating activity of a polypeptide, IDENTIFICATION METHOD (VARIANTS) AND APPLICATION OF COMPOUNDS METHOD OF IDENTIFICATION OF THE SUBJECT (OPTIONS) AND METHOD OF TREATING THE SUBJECT WITH DAMAGE ASSOCIATED WITH POTASSIUM CHANNELS (OPTIONS)
EP0688224A4 (en) A mutant protein and methods and materials for making and using it

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees